EUROPE’S BIOTECH MOMENT: WHAT THE BIOTECH ACT MUST DELIVER
Tracks
AUDITORIUM MARGARITA SALAS
| Tuesday, September 29, 2026 |
| 12:15 - 13:00 |
| AUDITORIUM MARGARITA SALAS |
Overview
Sponsor: MSD
Details
The year 2025 has been marked by the Biotech Act, the proposed Regulation through which the European Commission aims to establish a comprehensive regulatory framework to foster investment, innovation, and competitiveness in the biotechnology sector at a pivotal moment for Europe's strategic autonomy.
Against this backdrop, this session will explore how the Biotech Act represents an opportunity to strengthen the competitiveness of the Spanish biotechnology sector. In particular, the discussion will focus on some of the proposals expected to have the greatest impact on the industry, including Strategic Projects, financing pilots, the extension of the Supplementary Protection Certificate (SPC), and measures to accelerate clinical trials.
Speaker
Laura Pellisé
Government Affairs Director of Amgen & Member of the Board of AseBio
Amgen / AseBio
Moderator
Cristina Nadal Sanmartin
President of AseBio and Executive Director of Policy of MSD Spain
AseBio / MSD
.
Raquel Yotti
Comissioner for Avant-Garde Health
Ministry of Science, Innovation and Universities
.
Javier Padilla Benáldez
Secretary of State
Ministry of Health
.
Thomas Van Cangh
Deputy Head of Unit - Head of Biotech Taskforce
DG SANTE
.
AM Conferences & Meetings, S.L. - C/ Espronceda, 27 - 28003 Madrid